SARS-CoV-2 variants of concern have acquired mutations associated with an increased spike cleavage

Alba Escalera; Ana S. Gonzalez-Reiche; Sadaf Aslam; Ignacio Mena; Rebecca L. Pearl; Manon Laporte; Andrea Fossati; Raveen Rathnasinghe; Hala Alshammary; Adriana van de Guchte; Mehdi Bouhaddou; Thomas Kehrer; Lorena Zuliani-Alvarez; David A. Meekins; Velmurugan Balaraman; Chester McDowell; Juergen A Richt; Goran Bajic; Emilia Mia Sordillo; Nevan Krogan; Viviana Simon; Randy A. Albrecht; Harm van Bakel; Adolfo Garcia-Sastre; Teresa Aydillo.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-455290

Documentos relacionados

  1. In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.
  2. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron.
  3. Cross protection to SARS-CoV-2 variants in hamsters with naturally-acquired immunity.
  4. Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.
  5. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity.
  6. The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
  7. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
  8. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.
  9. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
  10. The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.